Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts
about
Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109.The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivoEliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).Synthetic versus natural curcumin: bioequivalence in an in vitro oral mucositis modelMouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993).Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.New perspectives of curcumin in cancer prevention.Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro.Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells.A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.Establishment of tandem mass spectrometric fingerprint of novel antineoplastic curcumin analogues using electrospray ionization.
P2860
Q33636519-13F07DE0-24BE-4484-915E-1A4C7CFE4FEDQ34936837-DCC535FA-1954-4A74-8333-E25144978DA5Q35034180-374885D1-9340-4FDA-B41C-B7C0166487B8Q35092027-CBABEDB3-8DF9-4B86-AE62-8730E0F58A4EQ35360274-F2EC30B7-4FD4-4E11-B87C-7958DE2AF78CQ36446689-B8CF800D-8852-48FC-AC30-95AB1221C2E8Q36694988-4DA95D0A-DAC1-486F-A0CE-9DB223E2EE26Q36957733-A34140DD-C746-4D83-8920-3AD55287E54DQ37590102-D7A1E8B5-2B51-4EDC-B010-F79D806D5391Q37728618-F3F1AF28-75A3-454C-A703-9991810B9A7FQ38758760-2C84AB16-DDB9-4EB1-9546-738CC0ECA97AQ38938523-F7E78B56-CC08-4E03-BAE4-95CDBF42ED99Q39023495-F2857BAA-2914-4DBD-B2E6-D362F389F9C1Q40777873-58FAF5E7-706F-4D97-BF5A-01C3ECA3698DQ52618019-252042F3-1E04-4DE9-9B43-CF90A534DC57Q53111716-4D1C1E52-2EE2-4E1D-AE35-D2AD45943A50Q53338281-330EA17E-DC1E-4B22-8493-36E80677A516
P2860
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic curcumin analog EF31 ...... mous cell carcinoma xenografts
@en
Synthetic curcumin analog EF31 ...... ous cell carcinoma xenografts.
@nl
type
label
Synthetic curcumin analog EF31 ...... mous cell carcinoma xenografts
@en
Synthetic curcumin analog EF31 ...... ous cell carcinoma xenografts.
@nl
prefLabel
Synthetic curcumin analog EF31 ...... mous cell carcinoma xenografts
@en
Synthetic curcumin analog EF31 ...... ous cell carcinoma xenografts.
@nl
P2093
P2860
P921
P356
P1433
P1476
Synthetic curcumin analog EF31 ...... mous cell carcinoma xenografts
@en
P2093
Aiming Sun
Alessandra Mancini
Deborah Culver
Dong M Shin
Fadlo R Khuri
Gabriel Sica
Hongzheng Zhang
James P Snyder
Mamoru Shoji
P2860
P304
P356
10.1039/C2IB20007D
P577
2012-04-25T00:00:00Z